COMAI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.236
AS - Asia 5.354
EU - Europa 2.602
AF - Africa 994
SA - Sud America 951
Continente sconosciuto - Info sul continente non disponibili 183
OC - Oceania 110
Totale 18.430
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.581
SG - Singapore 1.447
VN - Vietnam 881
IT - Italia 777
CN - Cina 757
BR - Brasile 562
HK - Hong Kong 532
BD - Bangladesh 421
FR - Francia 226
DE - Germania 149
IN - India 141
FI - Finlandia 132
CA - Canada 128
PL - Polonia 117
NL - Olanda 99
GB - Regno Unito 98
TR - Turchia 91
JP - Giappone 89
AR - Argentina 88
SE - Svezia 88
RU - Federazione Russa 87
IQ - Iraq 72
PH - Filippine 61
MX - Messico 60
UA - Ucraina 60
ZA - Sudafrica 58
ID - Indonesia 55
IE - Irlanda 54
SA - Arabia Saudita 54
EC - Ecuador 52
PK - Pakistan 51
CO - Colombia 47
UZ - Uzbekistan 44
PE - Perù 41
BJ - Benin 39
CL - Cile 39
CR - Costa Rica 38
ES - Italia 38
IL - Israele 37
JO - Giordania 37
KE - Kenya 37
MY - Malesia 37
MA - Marocco 36
TN - Tunisia 36
TT - Trinidad e Tobago 36
BB - Barbados 35
RO - Romania 35
AL - Albania 34
CH - Svizzera 34
JM - Giamaica 34
TH - Thailandia 34
VE - Venezuela 34
BY - Bielorussia 33
ET - Etiopia 33
KH - Cambogia 33
AU - Australia 32
AE - Emirati Arabi Uniti 31
BE - Belgio 31
EG - Egitto 31
NO - Norvegia 31
PY - Paraguay 31
CM - Camerun 30
LU - Lussemburgo 30
PS - Palestinian Territory 30
UG - Uganda 30
PT - Portogallo 29
BA - Bosnia-Erzegovina 28
IR - Iran 28
PA - Panama 28
RS - Serbia 28
SI - Slovenia 28
AO - Angola 27
AZ - Azerbaigian 27
CW - ???statistics.table.value.countryCode.CW??? 27
DJ - Gibuti 27
GT - Guatemala 27
HN - Honduras 27
CZ - Repubblica Ceca 26
DO - Repubblica Dominicana 26
MK - Macedonia 26
NP - Nepal 26
NZ - Nuova Zelanda 26
KR - Corea 25
SK - Slovacchia (Repubblica Slovacca) 25
YT - Mayotte 25
ZW - Zimbabwe 25
AF - Afghanistan, Repubblica islamica di 24
AT - Austria 24
CG - Congo 24
CI - Costa d'Avorio 24
KG - Kirghizistan 24
KZ - Kazakistan 24
ME - Montenegro 24
BS - Bahamas 23
BZ - Belize 23
DZ - Algeria 23
EE - Estonia 23
SN - Senegal 23
TJ - Tagikistan 23
TW - Taiwan 23
Totale 17.146
Salva come PNG Salva come JPEG
Città #
Ashburn 1.069
San Jose 930
Singapore 875
Hong Kong 487
Fairfield 434
Santa Clara 260
Ho Chi Minh City 253
Houston 231
Hanoi 223
Woodbridge 207
Chandler 174
Los Angeles 171
New York 168
Boardman 165
Jacksonville 149
Seattle 147
Cambridge 134
Wilmington 129
Beijing 116
Council Bluffs 113
Milan 113
Lauterbourg 96
Princeton 94
Ann Arbor 79
Dallas 77
Bytom 74
Chicago 66
Atlanta 59
Medford 58
Helsinki 53
Orem 52
San Diego 52
Buffalo 51
Padova 50
Padua 50
Da Nang 49
Dublin 47
Rome 47
Des Moines 45
Munich 45
São Paulo 45
Phoenix 43
Dong Ket 42
Denver 39
Tashkent 38
Cotonou 36
San Francisco 33
Tokyo 33
Toronto 33
Amman 32
Bridgetown 31
Haiphong 30
Hefei 30
Phnom Penh 30
San José 30
Addis Ababa 29
Istanbul 29
Nairobi 28
Naples 28
Roxbury 28
Chennai 27
Frankfurt am Main 27
Kampala 27
Nanjing 27
Lappeenranta 26
Panama City 26
Salt Lake City 26
Lima 25
Montreal 25
Baku 24
London 24
Abidjan 23
Brooklyn 23
Dakar 23
Djibouti 23
Harare 23
Luanda 23
Baghdad 22
Bamako 22
Dushanbe 22
Kingston 22
Lusaka 22
Nassau 22
Ulan Bator 22
Amsterdam 21
Antananarivo 21
Bishkek 21
Johannesburg 21
Kuala Lumpur 21
Minsk 21
Rio de Janeiro 21
Stockholm 21
Vientiane 21
Warsaw 21
Willemstad 21
Ljubljana 20
Turku 20
Biên Hòa 19
Dili 19
Nuremberg 19
Totale 9.263
Salva come PNG Salva come JPEG
Nome #
Pharmacokinetics, Tolerability, and Safety of Esmethadone in Subjects with Chronic Kidney Disease or Hepatic Impairment 527
Epilepsy, antiepileptic drugs, and aggression: An evidence-based review 359
Differential function of melatonin MT1 and MT2 receptors in REM and NREM sleep 308
Melatonin, Melatonin Receptors and Sleep: Moving Beyond Traditional Views 298
The content of proteic and nonproteic (free and protein-bound) tryptophan in quinoa and cereal flours 265
A study of tryptophan metabolism via serotonin in ventricular cerebrospinal fluid in HIV-1 infection using a neuroendoscopic technique 265
Efficacy and Safety of Esmethadone (REL-1017) in Patients With Major Depressive Disorder and Inadequate Response to Standard Antidepressants: A Phase 3 Randomized Controlled Trial 262
Determinazione della 2-feniletilammina nelle fave di cacao 259
The content of protein and non-protein (free and protein-bound) tryptophan in Theobroma cacao beans 255
Endoscopic selective sampling of human ventricular CSF: a new perspective. 253
Tryptophan metabolism via serotonin in human CSF on different brain sites using a new neuroendoscopic technique 245
Is Poor Lithium Response in Individuals with Bipolar Disorder Associated with Increased Degradation of Tryptophan along the Kynurenine Pathway? Results of an Exploratory Study 240
Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanisms 232
An investigation on the role of 3-hydroxykynurenine in pigment formation by matrix-assisted laser desorption/ionization mass spectrometry 232
New Synthesis and Pharmacological Evaluation of Enantiomerically Pure (R)- and (S)-Methadone Metabolites as N-Methyl-d-aspartate Receptor Antagonists 230
A mass spectrometric investigation on the possible role of tryptophan and 7-hydroxytryptophan in melanogenesis 229
ANXIOLYTIC- AND PROCOGNITIVE-LIKE EFFECTS OF A 30-DAY CHRONIC TREATMENT WITH A LOW NON-PSYCHEDELIC DOSE OF PSILOCYBIN IN C57BL/6J MICE 225
Tryptophan via serotonin/kynurenine pathways abnormalities in a large cohort of aggressive inmates: Markers for aggression 218
The protein profile of Theobroma cacao L. seeds as obtained by matrix-assisted laser desorption/ionization mass spectrometry 217
Dopamine neuron dysfunction and loss in the PrknR275W mouse model of juvenile parkinsonism 211
Sleep Quality After Quetiapine Augmentation in Patients With Treatment-Resistant Depression and Personality Disorders 210
The role of peptides and proteins in melanoidin formation 210
Esmethadone-HCl (REL-1017): a promising rapid antidepressant 203
Effects of PEG-interferon alpha plus ribavirin on tryptophan metabolism in patients with chronic hepatitis C 201
Dysfunction in endocannabinoids, palmitoylethanolamide, and degradation of tryptophan into kynurenine in individuals with depressive symptoms 192
Triterpene Derivatives from Abies spectabilis Leaves of Nepalese Origin 190
N-methyl-D-aspartate Receptors and Depression: Linking Psychopharmacology, Pathology and Physiology in a Unifying Hypothesis for the Epigenetic Code of Neural Plasticity 187
Study of tryptophan metabolism via serotonin in cerebrospinal fluid of patients with noncommunicanting hydrocephalus using a new endoscopic technique 186
Reduction of serum serotonin precursors after veralipride treatment for postmenopausal hot flushes 186
An investigation on the possible role of melatonin in melanogenesis 185
Emerging mechanisms of psilocybin-induced neuroplasticity 184
Investigation of Genetic Variants Associated with Tryptophan Metabolite Levels via Serotonin and Kynurenine Pathways in Patients with Bipolar Disorder 183
Centella asiatica (L.) urban from Nepal: Quali-quantitative analysis of samples from several sites, and selection of high terpene containing populations for cultivation 183
Preoperative Peripheral Blood Serotonin and Kynurenine Levels Are Associated With Oncological Outcomes in Glioblastoma IDH-wt Patients 176
Tryptophan metabolites, cytokines, and fatty acid binding protein 2 in myalgic encephalomyelitis/chronic fatigue syndrome 173
Neuroinflammation and kynurenines in schizophrenia: Impact on cognition depending on cognitive functioning and modulatory properties in relation to cognitive remediation and aerobic exercise 171
Phytochemical and Antioxidant-Related Investigations on Barkof Abies spectabilis (D. Don) Spach. from Nepal 169
Long-Term Safety and Efficacy of Esmethadone in Patients With Major Depressive Disorder 165
Early dysfunction of substantia nigra dopamine neurons in the parkinq311x mouse 163
A Tryptophan metabolism via serotonin in human CSF of different brain sites using a new neuroendoscopic technique 162
Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiome 160
Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: A novel target in psychopharmacology 158
Psychedelics and schizophrenia: a double-edged sword 148
Melatonin Regulates Neuronal Synaptic Plasticity in the Supramammillary Nucleus and Attenuates Methamphetamine-Induced Conditioned Place Preference and Sensitization in Mice 146
Neuronal PCSK9 regulates cognitive performances via the modulation of ApoER2 synaptic localization 146
The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users 145
The kynurenine pathway in treatment-resistant schizophrenia at the crossroads between pathophysiology and pharmacotherapy 145
Dysfunction of serotonergic activity and emotional responses across the light-dark cycle in mice lacking melatonin MT2 receptors 145
Targeting melatonin MT2 receptors: A novel pharmacological avenue for inflammatory and neuropathic pain 141
Two phenolic glycosides from Curculigo orchioides Gaertn 138
The clock is ticking on schizophrenia: a study protocol for a translational study integrating phenotypic, genomic, microbiome and biomolecular data to overcome disability 137
Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain 137
Acute and Chronic Pain Preclinical Models to Study the Analgesic Properties of Melatonergic Compounds 137
Repeated lysergic acid diethylamide (LSD) reverses stress-induced anxiety-like behavior, cortical synaptogenesis deficits and serotonergic neurotransmission decline 134
Melatonin and aggressive behavior: A systematic review of the literature on preclinical and clinical evidence 131
A DROSOPHILA APPROACH TO STUDY THE EFFECTS OF ATYPICAL ANTIPSYCHOTIC DRUGS 130
NEUROCYTOKYNES CHANGES INDUCING PEG-INTERFERON-ALPHA DEPRESSION: A RATIONAL APPROACH TO INCREASE ADHERENCE OF THERAPY IN CHRONIC HEPATITIS C 127
Therapeutic modulation of the kynurenine pathway in severe mental illness and comorbidities: A potential role for serotonergic psychedelics 125
D-Lysergic Acid Diethylamide (LSD) as a model of psychosis: Mechanism of action and pharmacology 125
Neuropathic pain impairs sleep architecture, non-rapid eye movement sleep, and reticular thalamic neuronal activity 124
Promotion of non-rapid eye movement sleep and activation of reticular thalamic neurons by a novel MT 2 melatonin receptor ligand 123
The hallucinogen D-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors 122
Biomarkers in aggression 121
Probing the Association between Cognition, Suicidal Behavior and Tryptophan Metabolism in a Sample of Individuals Living with Bipolar Disorder: A Secondary Analysis 120
Antinociceptive properties of selective MT2 melatonin receptor partial agonists 120
High frequency stimulation of the anterior vermis modulates behavioural response to chronic stress: involvement of the prefrontal cortex and dorsal raphe? 120
Melatonin recovers sleep phase delayed by MK-801 through the melatonin MT2 receptor- Ca2+-CaMKII-CREB pathway in the ventrolateral preoptic nucleus 119
Kynurenine amplifies tetrahydrocannabinol-induced sensorimotor impairment and classic "tetrad" effects in mice 118
Lysergic acid diethylamide differentially modulates the reticular thalamus, mediodorsal thalamus, and infralimbic prefrontal cortex: An in vivo electrophysiology study in male mice 118
Age-Related Effects of Exogenous Melatonin on Anxiety-like Behavior in C57/B6J Mice 117
Contenuto di triptofano non proteico (libero e legato alle proteine) nelle farine di cereali e legumi 117
Effects of kynurenine pathway metabolites on choroid plexus volume, hemodynamic response, and spontaneous neural activity: A new mechanism for disrupted neurovascular communication and impaired cognition in mood disorders 116
Sleep-wake characterization of double MT1/MT2 receptor knockout mice and comparison with MT1 and MT2 receptor knockout mice 116
Lifetime Cannabis Use Disorder Is Not Associated With Lifetime Impulsive Behavior and Severe Violence in Patients With Schizophrenia Spectrum Disorders From a High-Security Hospital 116
Letter to the Editor regarding ‘Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone’ 114
Role of palmitoylethanolamide (PEA) in depression: Translational evidence: Special Section on “Translational and Neuroscience Studies in Affective Disorders”. Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders 114
Metabolic Syndrome and Schizophrenia: Adding a Piece to the Interplay Between the Kynurenine Pathway and Inflammation 113
Translational research in suicide: Is it possible to study suicide in animal models? 113
Selective Enhancement of REM Sleep in Male Rats through Activation of Melatonin MT1 Receptors Located in the Locus Ceruleus Norepinephrine Neurons 112
Sleep well. Untangling the role of melatonin MT1 and MT2 receptors in sleep 111
Psychopathological and sociodemographic features in treatment-resistant unipolar depression versus bipolar depression: A comparative study 110
Melatonin MT1 and MT2 receptors exhibit distinct effects in the modulation of body temperature across the light/dark cycle 110
Melatonin, selective and non-selective MT1/MT2 receptors agonists: Differential effects on the 24-h vigilance states 109
Activation of Kv7 channels normalizes hyperactivity of the VTA-NAcLat circuit and attenuates methamphetamine-induced conditioned place preference and sensitization in mice 107
Enzimi scavenger nell'invecchiamento 106
Composition of cacao beans 106
Genomics and pharmacogenomics of cluster headache: implications for personalized management? A systematic review 105
Melatonin MT1 receptor as a novel target in neuropsychopharmacology: MT1 ligands, pathophysiological and therapeutic implications, and perspectives 104
Drugs for insomnia beyond benzodiazepines: Pharmacology, clinical applications, and discovery 104
The role of motivation in eating disorders: understanding sex differences in the circuits 103
Serotonin Dysfunction, Aggressive Behavior, and Mental Illness: Exploring the Link Using a Dimensional Approach 103
Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission 102
Transcranial direct current stimulation of the mouse prefrontal cortex modulates serotonergic neural activity of the dorsal raphe nucleus 102
Effects of quetiapine and olanzapine in patients with psychosis and violent behavior: A pilot randomized, open-label, comparative study 102
Melancholic-like behaviors and circadian neurobiological abnormalities in melatonin MT1 receptor knockout mice 102
The psychopharmacology of aggressive behavior: A translational approach: Part 2: Clinical studies using atypical antipsychotics, anticonvulsants, and lithium 102
Investigating the relationship between melatonin levels, melatonin system, microbiota composition and bipolar disorder psychopathology across the different phases of the disease 101
Sex Differences in Responses to Antidepressant Augmentations in Treatment-Resistant Depression 100
Biological Factors Underpinning Suicidal Behaviour: An Update 99
Moving toward precision and personalized treatment strategies in psychiatry 99
Totale 16.204
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.416
article - articoli 48.461
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 154
selected - selezionate 0
volume - volumi 1.737
Totale 102.768
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022722 0 25 64 31 138 6 12 73 143 2 51 177
2022/2023459 123 47 13 22 61 60 14 25 39 1 33 21
2023/2024370 11 39 35 29 17 41 24 16 23 13 70 52
2024/20252.032 9 99 106 45 149 146 118 148 198 104 353 557
2025/202611.501 383 790 1.663 1.831 875 412 1.292 944 1.198 703 673 737
2026/20271.851 1.248 603 0 0 0 0 0 0 0 0 0 0
Totale 18.430